{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:15:32Z","timestamp":1788380132761,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007052","name":"Memorial Sloan Kettering Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["advancessurgery.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.yasu.2026.03.004","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:31:58Z","timestamp":1779190318000},"page":"49-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Omission of Axillary Surgery for Low-Risk Breast Cancer"],"prefix":"10.1016","volume":"60","author":[{"given":"Kate R.","family":"Pawloski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea V.","family":"Barrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.yasu.2026.03.004_bib1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00000658-189407000-00075","article-title":"The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June, 1889, to January, 1894","volume":"20","author":"Halsted","year":"1894","journal-title":"Ann Surg"},{"issue":"8","key":"10.1016\/j.yasu.2026.03.004_bib2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa020128","article-title":"Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.yasu.2026.03.004_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","article-title":"Lymphatic mapping and sentinel lymphadenectomy for breast cancer","volume":"220","author":"Giuliano","year":"1994","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.yasu.2026.03.004_bib4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.yasu.2026.03.004_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0960-7404(93)90064-6","article-title":"Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe","volume":"2","author":"Krag","year":"1993","journal-title":"Surg Oncol"},{"issue":"4","key":"10.1016\/j.yasu.2026.03.004_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/SLA.0b013e3181c0e92a","article-title":"Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study","volume":"251","author":"Veronesi","year":"2010","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.yasu.2026.03.004_bib7","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial","volume":"15","author":"Donker","year":"2014","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.yasu.2026.03.004_bib8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.yasu.2026.03.004_bib9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"Giuliano","year":"2016","journal-title":"Ann Surg"},{"issue":"12","key":"10.1016\/j.yasu.2026.03.004_bib10","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.22.01565","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-Year results of the randomized controlled EORTC 10981-22023 AMAROS trial","volume":"41","author":"Bartels","year":"2023","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.yasu.2026.03.004_bib11","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.2017.11470","article-title":"Effect of axillary dissection vs No axillary dissection on 10-Year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial","volume":"318","author":"Giuliano","year":"2017","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.yasu.2026.03.004_bib12","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes","year":"2013","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.yasu.2026.03.004_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1200\/JCO.2005.01.5784","article-title":"Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of international breast cancer study group trial 10-93","volume":"24","author":"Rudenstam","year":"2006","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.yasu.2026.03.004_bib14","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1097\/SLA.0b013e31827660a8","article-title":"Axillary dissection versus no axillary dissection in older patients with T1N0 breast cancer: 15-year results of a randomized controlled trial","volume":"256","author":"Martelli","year":"2012","journal-title":"Ann Surg"},{"issue":"2","key":"10.1016\/j.yasu.2026.03.004_bib15","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.surg.2023.03.023","article-title":"Omitting axillary staging in selected patients: rationale of choosing wisely in breast cancer treatment","volume":"174","author":"Grossi","year":"2023","journal-title":"Surgery"},{"key":"10.1016\/j.yasu.2026.03.004_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.surg.2024.08.047","article-title":"Implementation of choosing wisely guidelines: omission of lymph node surgery","volume":"179","author":"Whitrock","year":"2025","journal-title":"Surgery"},{"issue":"8","key":"10.1016\/j.yasu.2026.03.004_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yasu.2026.03.004_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1471-2407-14-177","article-title":"Analytical validation of the PAM50-based prosigna breast cancer prognostic gene signature assay and nCounter analysis system using formalin-fixed paraffin-embedded breast tumor specimens","volume":"14","author":"Nielsen","year":"2014","journal-title":"BMC Cancer"},{"issue":"27","key":"10.1016\/j.yasu.2026.03.004_bib19","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","article-title":"A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer","volume":"351","author":"Paik","year":"2004","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.yasu.2026.03.004_bib20","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1200\/JCO.2005.04.7985","article-title":"Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer","volume":"24","author":"Paik","year":"2006","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.yasu.2026.03.004_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1470-2045(09)70314-6","article-title":"Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial","volume":"11","author":"Albain","year":"2010","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.yasu.2026.03.004_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-Gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N Engl J Med"},{"issue":"25","key":"10.1016\/j.yasu.2026.03.004_bib23","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-Gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.yasu.2026.03.004_bib24","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1245\/s10434-022-12203-x","article-title":"Axillary staging is not justified in postmenopausal clinically node-negative women based on nodal disease burden","volume":"30","author":"Lee","year":"2023","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.yasu.2026.03.004_bib25","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.1245\/s10434-022-12056-4","article-title":"Prevalence of pathologic N2\/N3 disease in postmenopausal women with clinical N0 ER+\/HER2- breast cancer","volume":"29","author":"Amlicke","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.yasu.2026.03.004_bib26","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jamaoncol.2023.3759","article-title":"Sentinel lymph node biopsy vs no axillary surgery in patients with small breast cancer and negative results on ultrasonography of axillary lymph nodes: the SOUND randomized clinical trial","volume":"9","author":"Gentilini","year":"2023","journal-title":"JAMA Oncol"},{"issue":"1","key":"10.1016\/j.yasu.2026.03.004_bib27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12885-022-09273-1","article-title":"No axillary surgical treatment for lymph node-negative patients after ultra-sonography [NAUTILUS]: protocol of a prospective randomized clinical trial","volume":"22","author":"Jung","year":"2022","journal-title":"BMC Cancer"},{"issue":"11","key":"10.1016\/j.yasu.2026.03.004_bib28","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJMoa2412063","article-title":"Axillary surgery in breast cancer - primary results of the INSEMA trial","volume":"392","author":"Reimer","year":"2025","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.yasu.2026.03.004_bib29","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1186\/s12885-017-3443-x","article-title":"Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08)","volume":"17","author":"van Roozendaal","year":"2017","journal-title":"BMC Cancer"},{"issue":"5","key":"10.1016\/j.yasu.2026.03.004_bib30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ejso.2016.01.020","article-title":"Physical function of the upper limb after breast cancer surgery. Results from the SOUND (sentinel node vs. observation after axillary Ultra-souND) trial","volume":"42","author":"Gentilini","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.yasu.2026.03.004_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101756","article-title":"Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): a randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancer","volume":"55","author":"Reimer","year":"2023","journal-title":"eClinicalMedicine"},{"issue":"14","key":"10.1016\/j.yasu.2026.03.004_bib32","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1200\/JCO-25-00099","article-title":"Sentinel lymph node biopsy in early-stage breast cancer: ASCO guideline update","volume":"43","author":"Park","year":"2025","journal-title":"J Clin Oncol"},{"issue":"34","key":"10.1016\/j.yasu.2026.03.004_bib33","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1200\/JCO.20.02514","article-title":"Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER2-node-positive, high-risk, early breast cancer (monarchE)","volume":"38","author":"Johnston","year":"2020","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.yasu.2026.03.004_bib34","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1200\/JCO.21.02742","article-title":"FDA approval summary: abemaciclib with endocrine therapy for high-risk early breast cancer","volume":"40","author":"Royce","year":"2022","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.yasu.2026.03.004_bib35","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1200\/JCO.23.01994","volume":"42","author":"Rastogi","year":"2024","journal-title":"J Clin Oncol"},{"issue":"12","key":"10.1016\/j.yasu.2026.03.004_bib36","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1056\/NEJMoa2305488","article-title":"Ribociclib plus endocrine therapy in early breast cancer","volume":"390","author":"Slamon","year":"2024","journal-title":"N Engl J Med"},{"issue":"10099","key":"10.1016\/j.yasu.2026.03.004_bib37","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","article-title":"Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial","volume":"390","author":"Coles","year":"2017","journal-title":"Lancet"},{"issue":"35","key":"10.1016\/j.yasu.2026.03.004_bib38","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1200\/JCO.20.00650","article-title":"Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-Florence trial","volume":"38","author":"Meattini","year":"2020","journal-title":"J Clin Oncol"},{"issue":"10215","key":"10.1016\/j.yasu.2026.03.004_bib39","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial","volume":"394","author":"Vicini","year":"2019","journal-title":"Lancet"},{"issue":"10215","key":"10.1016\/j.yasu.2026.03.004_bib40","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/S0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial","volume":"394","author":"Whelan","year":"2019","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.yasu.2026.03.004_bib41","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1415369","article-title":"Internal mammary and medial supraclavicular irradiation in breast cancer","volume":"373","author":"Poortmans","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.yasu.2026.03.004_bib42","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early-stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yasu.2026.03.004_bib43","unstructured":"Canadian Cancer Trials Group. Tailor RT: a randomized trial of regional radiotherapy in biomarker low-risk node positive and T3N0 breast cancer. Available at: https:\/\/clinicaltrials.gov\/study\/NCT03488693. Accessed November 2, 2025."},{"issue":"4","key":"10.1016\/j.yasu.2026.03.004_bib44","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1200\/JCO.23.02270","article-title":"Omission of radiotherapy after breast-conserving surgery for women with breast cancer with low clinical and genomic risk: 5-year outcomes of IDEA","volume":"42","author":"Jagsi","year":"2024","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.yasu.2026.03.004_bib45","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1056\/NEJMoa2302344","article-title":"Omitting radiotherapy after breast-conserving surgery in luminal a breast cancer","volume":"389","author":"Whelan","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.yasu.2026.03.004_bib46","unstructured":"NRGOncology. A phase III clinical trial evaluating De-Escalation of breast radiation for conservative treatment of stage I, hormone sensitive, HER-2 negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer. Available at: https:\/\/clinicaltrials.gov\/study\/NCT04852887. Accessed November 2, 2025."}],"container-title":["Advances in Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065341126000047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065341126000047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:28:41Z","timestamp":1788377321000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065341126000047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0065341126000047"],"URL":"https:\/\/doi.org\/10.1016\/j.yasu.2026.03.004","relation":{},"ISSN":["0065-3411"],"issn-type":[{"value":"0065-3411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omission of Axillary Surgery for Low-Risk Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Advances in Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yasu.2026.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}